SRNE news https://www.marketwatch.com/press-release/sorrento-enters-into-binding-term-sheet-to-acquire-exclusive-rights-to-abivertinib-with-completed-registrational-trial-data-in-non-small-cell-lung-cancer-2020-05-21?siteid=bigcharts&dist=bigcharts&tesla=y